Cardiff Oncology, Inc.
Latest Stock Split
Feb 20, 2019
1:6
For every 6 shares held, investors received 1.
The split itself did not change the total investment value.
Use this split data in your app
Build with our dataStock Split History
- Feb 20, 2019Before—Split ratio1:6After—Reverse
- Jun 04, 2018Before—Split ratio1:12After—Reverse
- May 30, 2012Before—Split ratio1:6After—Reverse
- Jul 27, 2004Before—Split ratio111:1After—Forward
About Cardiff Oncology, Inc. stock splits
Cardiff Oncology, Inc. (GETTEX:XE7C) operates in the Medical specialties industry.
Cardiff Oncology, Inc. company overviewWhen did Cardiff Oncology, Inc. stock split?
Cardiff Oncology, Inc.'s most recent stock split was on February 20, 2019. It was a 1-for-6 reverse split, so shareholders received 1 share for every 6 they held.
What is Cardiff Oncology, Inc.'s stock split history?
Cardiff Oncology, Inc. (GETTEX:XE7C) has split its stock 4 times: a 111-for-1 split on July 27, 2004, a 1-for-6 reverse split on May 30, 2012, a 1-for-12 reverse split on June 4, 2018, and a 1-for-6 reverse split on February 20, 2019.
How many times has Cardiff Oncology, Inc. stock split?
Cardiff Oncology, Inc. has split its stock 4 times. This history records 4 splits between July 27, 2004 and February 20, 2019.
What is a reverse stock split?
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Cardiff Oncology, Inc.'s 1-for-6 reverse split on February 20, 2019, every 6 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Will Cardiff Oncology, Inc. split its stock again?
Cardiff Oncology, Inc. has not announced a new split in our records. Its most recent split was on February 20, 2019, 7 years ago. Companies announce splits in advance, and any new GETTEX:XE7C split will appear on this page.